Doctor profile · Federal record
Dr. Alireza Eghtedar, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Emergency Medicine Physician · Internal Medicine Physician · Denver, CO
- NPI 1811280431
- Accepts Medicare
- MIPS 71.9 / 100 · 2023
- 27 yrs in practice
- Licensed in 3 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1721 E 19Th Ave Ste 300
Denver, CO 802181258
(720) 754-4800
fax (720) 754-4801 - Mailing address
-
4900 S Monaco St Ste 210
Denver, CO 802373487
Credentials & registration
- NPI registered
- May 2011 — 15 yrs on file
- Profile last updated
- July 19, 2019
- Year of graduation
- 1999 — 27 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (3)
- Colorado #55429 · Texas #N9365 · Michigan #4301099957
- Medicaid
- CO #78133530
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1811280431. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
11,670
Distinct HCPCS
10
Medicare allowed
$522,782
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 8,100 | 26 | $48 | |
J1568 |
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 1,470 | 21 | $42 | |
J3475 |
Injection, magnesium sulfate, per 500 mg | 624 | 28 | $1 | |
36415 |
Insertion of needle into vein for collection of blood sample | 423 | 81 | $8 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 232 | 14 | $0 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 162 | 60 | $177 | |
96366 |
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 159 | 47 | $21 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 109 | 59 | $66 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 87 | 47 | $75 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 61 | 34 | $136 |
In context: peer comparison
Among 15 peers in this city , average services per provider: 845. This provider delivers 14× the peer median.Open Payments
Industry payments received
All-time total
$394
Transactions
13
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $145.51 | |
| Blueprint Medicines Corporation | 2 | $50.62 | |
| Astellas Pharma US Inc | 2 | $48.02 | |
| ABBVIE INC. | 2 | $37.64 | |
| Daiichi Sankyo Inc. | 2 | $36.06 | |
| Incyte Corporation | 1 | $22.15 | |
| Genmab U.S., Inc. | 1 | $19.41 | |
| GlaxoSmithKline, LLC. | 1 | $18.61 | |
| Celgene Corporation | 1 | $16.21 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
643
Patients
55
Total drug cost
$963,936
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Valacyclovir (Valacyclovir Hcl) | Brand | 136 | 24 | $7,957 |
| Acyclovir | Generic | 91 | 19 | $1,828 |
| Jakafi (Ruxolitinib Phosphate) | Brand | 45 | 0 | $702,826 |
| Fluconazole | Generic | 44 | 0 | $4,256 |
| Potassium Chloride | Generic | 40 | 0 | $570 |
| Sirolimus | Generic | 40 | 0 | $5,848 |
| Lisinopril | Generic | 38 | 0 | $242 |
| Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) | Brand | 34 | 12 | $173 |
| Allopurinol | Generic | 32 | 0 | $217 |
| Pantoprazole Sodium | Generic | 32 | 0 | $323 |
Hospital affiliations
Frequently asked questions
What is Dr. Alireza Eghtedar's medical specialty?
Dr. Alireza Eghtedar practices Hematology & Oncology Physician in Denver, CO.
Where does Dr. Alireza Eghtedar practice?
Dr. Alireza Eghtedar practices at 1721 E 19Th Ave Ste 300, Denver, CO 802181258. Office phone: 7207544800.
What is Dr. Alireza Eghtedar's NPI?
Dr. Alireza Eghtedar's National Provider Identifier (NPI) is 1811280431, issued by NPPES.
Does Dr. Alireza Eghtedar accept Medicare assignment?
Yes. Dr. Alireza Eghtedar accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Alireza Eghtedar commonly perform?
Top Medicare-reported procedures in 2023: Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144); Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS J1568); Injection, magnesium sulfate, per 500 mg (HCPCS J3475). Source: CMS Medicare Physician & Other Practitioners file.